HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%

Reuters

07/25

HCA Healthcare <a href="https://laohu8.com/S/QTWO">Q2</a> Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%

HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2554957764"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2554957764\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2554957764?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-25 19:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554957764","market":"nz","top_or_hot":-1,"title":"HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      HCA Healthcare <a href=\"https://laohu8.com/S/QTWO\">Q2</a> Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-07-25 19:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      HCA Healthcare <a href=\"https://laohu8.com/S/QTWO\">Q2</a> Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCA","symbol_name":"HCA控股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL9VMrKB:1","article_id":"2554957764","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554957764","pubTimestamp":1753443032,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"HCA":"HCA控股"},"translate_title":"HCA Healthcare第二季度业绩：收入增长6.4%至$18.605 B，净利润增长13.1%，每股收益增长23.5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCA":0.9},"content_text":"HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%\n    \n\n        HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}